Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sonoma Pharmaceuticals's share price for the quarter that ended in Dec. 2023 was $0.1804. Sonoma Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 13.68 Mil. Therefore, Sonoma Pharmaceuticals's market cap for the quarter that ended in Dec. 2023 was $2.47 Mil.
Sonoma Pharmaceuticals's quarterly market cap
declined
from Jun. 2023 ($5.50 Mil) to Sep. 2023 ($4.00 Mil) and
declined
from Sep. 2023 ($4.00 Mil) to Dec. 2023 ($2.47 Mil).
Sonoma Pharmaceuticals's annual market cap
declined
from Mar. 2021 ($15.55 Mil) to Mar. 2022 ($12.43 Mil) and
declined
from Mar. 2022 ($12.43 Mil) to Mar. 2023 ($4.82 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sonoma Pharmaceuticals's Enterprise Value for Today is $0.44 Mil.
Sonoma Pharmaceuticals Market Cap Historical Data
The historical data trend for Sonoma Pharmaceuticals's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Sonoma Pharmaceuticals Annual Data
Trend
Mar14
Mar15
Mar16
Mar17
Mar18
Mar19
Mar20
Mar21
Mar22
Mar23
Market Cap
11.14
8.71
15.55
12.43
4.82
Sonoma Pharmaceuticals Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
Market Cap
3.48
4.82
5.50
4.00
2.47
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Sonoma Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sonoma Pharmaceuticals Market Cap Distribution
For the Drug Manufacturers industry and Healthcare sector, Sonoma Pharmaceuticals's Market Cap distribution charts can be found below:
* The bar in red indicates where Sonoma Pharmaceuticals's Market Cap falls into.
Sonoma Pharmaceuticals Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sonoma Pharmaceuticals's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sonoma Pharmaceuticals (NAS:SNOA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sonoma Pharmaceuticals Market Cap Related Terms
Thank you for viewing the detailed overview of Sonoma Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Sonoma Pharmaceuticals (Sonoma Pharmaceuticals) Business Description
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SNOA has been successfully added to your 